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Autotaxin-LPA signaling contributes to obesity-induced
insulin resistance in muscle and impairs mitochondrial
metabolism
Kenneth D’Souza,* Carine Nzirorera,* Andrew M. Cowie,* Geena P. Varghese,* Purvi Trivedi,*
Thomas O. Eichmann,† Dipsikha Biswas,* Mohamed Touaibia,§ Andrew J. Morris,**
Vassilis Aidinis,†† Daniel A. Kane,§§ Thomas Pulinilkunnil,* and Petra C. Kienesberger1,*

ORCID IDs: 0000-0002-2734-188X (K.D.); 0000-0002-8521-2795 (T.O.E.); 0000-0001-9531-7729 (V.A.);
0000-0003-1228-893X (T.P.); 0000-0001-9643-8338 (P.C.K.)

Abstract Autotaxin (ATX) is an adipokine that generates
the bioactive lipid, lysophosphatidic acid (LPA). ATX-LPA
signaling has been implicated in diet-induced obesity and
systemic insulin resistance. However, it remains unclear
whether the ATX-LPA pathway influences insulin function
and energy metabolism in target tissues, particularly skeletal
muscle, the major site of insulin-stimulated glucose disposal.
The objective of this study was to test whether the ATX-LPA
pathway impacts tissue insulin signaling and mitochondrial
metabolism in skeletal muscle during obesity. Male mice with
heterozygous ATX deficiency (ATX+/) were protected from
obesity, systemic insulin resistance, and cardiomyocyte dysfunction following high-fat high-sucrose (HFHS) feeding.
HFHS-fed ATX+/ mice also had improved insulin-stimulated
AKT phosphorylation in white adipose tissue, liver, heart,
and skeletal muscle. Preserved insulin-stimulated glucose
transport in muscle from HFHS-fed ATX+/ mice was associated with improved mitochondrial pyruvate oxidation in the
absence of changes in fat oxidation and ectopic lipid accumulation. Similarly, incubation with LPA decreased insulinstimulated AKT phosphorylation and mitochondrial energy
metabolism in C2C12 myotubes at baseline and following

Autotaxin (ATX) is a lysophospholipase D that is also
known as ecto-nucleotide pyrophosphatase/phosphodiesterase family member 2 (ENPP2) (1), and generates the
majority of extracellular lysophosphatidic acid (LPA) by
hydrolyzing the lysophosphatidylcholine (LPC) contained
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palmitate-induced insulin resistance. Taken together, our results suggest that the ATX-LPA pathway contributes to obesityinduced insulin resistance in metabolically relevant tissues.
Our data also suggest that LPA directly impairs skeletal muscle insulin signaling and mitochondrial function.—D’Souza,
K., C. Nzirorera, A. M. Cowie, G. P. Varghese, P. Trivedi,
T. O. Eichmann, D. Biswas, M. Touaibia, A. J. Morris, V. Aidinis,
D. A. Kane, T. Pulinilkunnil, and P. C. Kienesberger. Autotaxin-LPA signaling contributes to obesity-induced insulin
resistance in muscle and impairs mitochondrial metabolism.
J. Lipid Res. 2018. 59: 1805–1817.
Supplementary key words diet effects/lipid metabolism • glucose •
pyruvate • skeletal muscle • respiration
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enhanced glucose tolerance and insulin sensitivity in highfat diet-fed mice in the absence of changes in adiposity,
which was mainly ascribed to increased islet cell number,
glycogen storage in the liver, and muscle glucose oxidation (24).
Despite growing evidence suggesting that the ATX-LPA
pathway impacts glucose homeostasis and global insulin
sensitivity in mice and humans, it remains unclear whether
ATX-LPA signaling influences insulin sensitivity through
direct or indirect effects of LPA on insulin target tissues.
In particular, it is incompletely understood whether the
ATX-LPA pathway modulates insulin function and energy
metabolism in skeletal muscle, which accounts for the majority of insulin-mediated glucose disposal (25). Therefore,
we examined tissue insulin signaling in mice with global
heterozygous ATX deficiency subjected to diet-induced
obesity and tested to determine whether the ATX-LPA
pathway influences glucose and lipid metabolism in skeletal muscle.
Our study shows that: 1) partial ATX deficiency protects
from impaired insulin signaling in white adipose tissue,
liver, heart, and skeletal muscle following high-fat highsucrose (HFHS) feeding, as is reflected in reduced weight
gain, improved glucose and insulin tolerance, and blunted
cardiomyocyte dysfunction in male HFHS-fed ATX+/ mice;
2) HFHS-fed ATX+/ mice are resistant to impaired insulin-stimulated glucose transport in skeletal muscle and
have improved mitochondrial pyruvate oxidation; and
3) in C2C12 myotubes, incubation with LPA reduces insulinstimulated AKT phosphorylation at baseline and exacerbates palmitate-induced insulin resistance, coincident with
impaired mitochondrial respiration. Taken together, these
data suggest that the ATX-LPA pathway negatively regulates muscle insulin signaling and mitochondrial function.

MATERIALS AND METHODS
Chemicals and reagents
Unless otherwise stated, chemicals and reagents were obtained
from Sigma.

Animals
The generation of ATX+/ mice (C57Bl/6-Enpp2<tm1.1Vart>/
FLMG) and genotyping instructions have been previously reported (26). Briefly, loxP-flanked neomycin selection cassettes
were inserted upstream of exon 1 and downstream of exon 2 (26).
Transgenic expression of Cre recombinase in mice bearing this
allele resulted in excision of both exons, thus abolishing protein
expression. Mice were housed on a 12 h light:12 h dark cycle with
ad libitum access to chow diet (LD5001 from LabDiet with
13.5 kcal% from fat) or HFHS diet (12451 from Research Diets
with 45 kcal% from fat and 17 kcal% from sucrose) and water.
Male and female mice (7–9 weeks old) were randomly assigned to
chow or HFHS cohorts and fed for 20 weeks. For food intake studies, mice were individually housed and food consumption was
monitored daily over a 5 day period 2 weeks post diet start. Mice
were subjected to an insulin tolerance test (ITT) or glucose tolerance test (GTT) at 15 and 17 weeks post diet start, respectively.
Peripheral fat accumulation in isofluorane-anesthetized mice was
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in lipoproteins and activated platelets (1–3). Despite its
ubiquitous expression, a substantial proportion of circulating ATX emanates from the adipose tissue. Indeed, adipose-specific ATX knockout mice exhibit 50% reduced
plasma LPA (4, 5). ATX-LPA signaling through G proteincoupled receptors (LPA1–6) influences many biological
processes, including brain development, embryo implantation, vasculogenesis, and hair follicle formation (6).
Signaling effectors downstream of LPA receptors include
PI3Kinase-AKT-Ras-related C3 botulinum toxin substrate 1
activation, modulation of adenylate cyclase, stimulation of
the mitogen-activated protein kinase pathway, Rho and
Rho kinase activation, and stimulation of the phospholipase C-protein kinase C pathway (7).
The ATX-LPA signaling axis plays an important role in
many disease states, such as cancer, cardiovascular disease,
neuropathic pain, pulmonary fibrosis, and arthritis (2,
8–12). Notably, the ATX-LPA axis has been explored as a
therapeutic target in diseases associated with chronic inflammation (13, 14). At least three compounds targeting
the ATX-LPA pathway have passed phase I and II clinical
trials for the treatment of idiopathic pulmonary fibrosis
and systemic sclerosis (13, 15), demonstrating that modulators of ATX-LPA receptor signaling have promising therapeutic potential. A recent study showed that genetic
deletion or long-term pharmacologic inhibition of ATX in
adult mice is well-tolerated, alleviating concerns that targeting the ATX-LPA pathway could elicit toxicity (16).
The ATX-LPA pathway has also been implicated in obesity and metabolic disease, specifically insulin resistance
and impaired glucose homeostasis (4, 5, 17–22). In humans, serum ATX correlates with measures of obesity, impaired glucose homeostasis, and insulin resistance (19, 20).
In addition, serum ATX is independently associated with
hepatic steatosis, a metabolic complication of obesity and
diabetes, in severely obese women (19). Studies in mice
showed that ATX-LPA signaling influences adiposity, although it remains incompletely understood whether the
ATX-LPA pathway promotes or protects from diet-induced
obesity and adipocyte hypertrophy (4, 5, 23). Dusaulcy
et al. (4) showed that high-fat-fed adipose-specific ATX
knockout mice have increased fat mass and adipocyte size.
On the other hand, Nishimura et al. (5) demonstrated that
adipose-specific and global heterozygous ATX knockout
(ATX+/) mice are protected from high-fat diet-induced
obesity (5). Brown adipose tissue (BAT) was functionally
more active, resulting in increased energy expenditure in
ATX-deficient mice (5). Moreover, ATX overexpression in
mice led to augmented obesity following high-fat feeding
(5, 23). Regardless of the effect of ATX-LPA on adiposity,
studies using global heterozygous or fat-specific ATX
knockout mice suggest that the ATX-LPA pathway contributes to high-fat diet-induced systemic insulin resistance
and impaired glucose homeostasis (4, 5). Consistent with
these studies, acute LPA injection resulted in impaired glucose tolerance in chow- and high-fat diet-fed mice through
inhibition of glucose-induced insulin secretion, an effect
that was blunted by Ki16425, a preferential LPA1/3 antagonist (24). Prolonged administration of Ki16425 for 3 weeks
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determined by X-ray imaging using a Bruker In-Vivo Xtreme imager 18 weeks post diet start. Planar X-ray images were analyzed
using ImageJ software (National Institutes of Health) and area of
peripheral fat was expressed as percent of total body area. Mice
were euthanized by decapitation following a 3 h food withdrawal
and tissues were collected. Perigonadal adipose tissue (PGAT)
and BAT were weighed prior to being flash-frozen. EDTA-plasma
was collected and spun at 15,600 g for 10 min at 4°C. For serum
collection, blood was spun at 2,000 g for 15 min at 4°C. Plasma
and serum were frozen and stored at 80°C until further use. All
protocols involving mice were approved by the Dalhousie University Institutional Animal Care and Use Committee.

Rpl27-fwd 5′-ACGGTGGAGCCTTATGTGAC-3′, Rpl27-rev 5′-TCCGTCAGAGGGACTGTCTT-3′, Rpl41-fwd 5′-GCCATGAGAGCGAAGTGG-3′, and Rpl41-rev 5′-CTCCTGCAGGCGTCGTAG-3′.

Plasma and serum analysis
Serum insulin was determined using an ELISA kit assay (Crystal Chem). NEFA (WAKO Chemicals) and triacylglycerol (TG)
(Thermo Fisher Scientific) analyses were performed using colorimetric kit assays, as per the manufacturer’s instructions. Plasma
LPA levels were determined by HPLC/ESI/MS/MS analysis as
previously described (29).

Cell culture

ITTs and GTTs

Insulin signaling studies
For insulin signaling studies performed in vivo, mice were
injected intraperitoneally with 10 U of insulin per kilogram
body weight or an equal volume of saline. After 10 min, mice
were euthanized and tissues were collected. For ex vivo insulin
signaling studies in muscle, isolated soleus muscles were preincubated for 30 min in pregassed (95% O2, 5% CO2) KrebsHenseleit bicarbonate buffer (KHB) (pH 7.4) (118.5 mM NaCl,
4.7 mM KCl, 1.2 mM KH2PO4, 25 mM NaCHO3, 2.5 mM CaCl2,
1.2 mM MgSO4, and 5 mM HEPES) at 37°C. Following subsequent incubation in buffer with or without 33 nM insulin for
10 min, muscles were removed; connective tissue, fat, and tendons were excised; and tissues were blotted dry and snap-frozen
in liquid nitrogen.

Muscle glucose transport assay
Glucose transport in soleus muscle was determined ex vivo as
previously described (27), with slight modifications. Soleus muscles from mice were rapidly dissected, preincubated for 1 h in
KHB containing 10 mM D-glucose at 37°C, and rinsed by incubation in KHB supplemented with 10 mM D-mannitol for 10 min.
Glucose transport was assessed by incubation in KHB with 1 mM
3
2-deoxyglucose, 9 mM mannitol, 1.5 Ci/ml 2-deoxy-D-[1,2- H]
14
glucose (Perkin Elmer), and 0.3 Ci/ml D-[1- C]mannitol (Perkin Elmer) for 20 min at 37°C. All buffers were pregassed with
95% O2, 5% CO2 and were supplemented with saline or 33 nM
insulin. Basal glucose transport and insulin-stimulated glucose
transport were determined in contralateral muscles. Following
the final incubation, muscles were cleaned by excising connective
tissue, fat, and tendons, and tissues were blotted dry and snapfrozen in liquid nitrogen. Muscles were weighed and digested
for 30 min in 300 l of 1 N NaOH at 65°C and centrifuged at
13,000 g for 10 min. Radioactivity in the supernatant was determined by liquid scintillation counting and glucose transport into
tissues was calculated.

Gene expression analysis
RNA isolation, reverse transcription, and real-time quantitative
PCR were performed as previously described (22, 28) using the
following primer sequences: Glut1-forward (fwd) 5′-GGTGTGCAGCAGCCTGTGTACG-3′, Glut1-reverse (rev) 5′-TAGGACATCCAAGGCAGCCGTTC-3′, Glut4-fwd 5′-ACCGGCAGCCTCTGATCATCG-3′, Glut4-rev 5′-GAGTGTCCGTCGTCCAGCTCGTT-3′,

Insulin resistance was induced in C2C12 cells as previously described (28). Briefly, cells were incubated in medium containing
2% (w/v) fatty acid-free (FAF)-BSA and 0.8 mM sodium palmitate
for 16–18 h. Myotubes were cultured with 2% FAF-BSA in the absence of palmitate to mimic an insulin-sensitive state. To examine
insulin signaling, cells were incubated with 100 nM insulin or PBS
for 15 min. Cells were washed once and harvested in ice-cold PBS,
followed by centrifugation at 20,000 g for 10 min at 4°C. Cell pellets were flash-frozen in liquid nitrogen and stored at 80°C until
further use. For experiments involving LPA, 1-oleoyl-2-hydroxy-snglycero-3-phosphate (18:1 LPA; Avanti) was dissolved in PBS with
0.1% FAF-BSA, gently shaken, and mixed with DMEM-1X supplemented with 5 mM glucose prior to its addition to C2C12 myotubes. Cells were cultured in the absence of serum during LPA
treatment to avoid potential additional sources of LPA, LPC,
and ATX.

Assessment of ATX activity
ATX activity in plasma and serum was quantified as previously
described (22, 30). Briefly, 2 l of plasma or serum were added to
18 l of buffer A containing 100 mM Tris-HCl (pH 9.0), 500 mM
NaCl, 5 mM MgCl2, and 0.05% v/v Triton X-100. For samples examined in the presence of the ATX inhibitor, PF-8380 (31), 5 l
of buffer A containing 10% DMSO or 5 mM of PF-8380 were
added. Samples were preincubated at 37°C for 30 min and 25 l
of 6 mM 1-myristoyl-2-hydroxy-sn-glycero-3-phosphocholine (14:0
LPC; Avanti) were added. The reaction mixture was incubated at
37°C for 6 h to allow for ATX-mediated choline release. Subsequently, 20 l of sample were incubated with 90 l of buffer C
{9.65 ml of buffer B [100 mM Tris-HCl (pH 8.5) and 5 mM CaCl2],
110 l of 30 mM N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3-methylaniline (TOOS; Cedarlane), 110 l of 50 mM 4-aminotipyrine, 6.6 l
of 1,000 U/ml horseradish peroxidase, and 110 l of 300 U/ml
choline oxidase} at 37°C for 20 min and choline oxidation was
recorded at 550 nm for 30 min.

Immunoblotting analysis
Tissues and cells were homogenized in lysis buffer [20 mM TrisHCl (pH 7.5), 5 mM EDTA, 10 mM Na4P2O7, 100 mM NaF, and
1% NP-40] containing 2 mM sodium orthovanadate, 2 mM protease inhibitor cocktail (P8340; Sigma), and 100 g/ml phosphatase inhibitor cocktail (524628; Calbiochem) using a tissue
homogenizer (Omni TH; Omni International) or by sonication,
respectively. Protein concentrations in tissue and cell lysates or
plasma were quantified colorimetrically using a BCA protein assay
kit (Thermo Scientific) and BSA as standard. Lysates or plasma
were subjected to SDS-PAGE and proteins were transferred onto
a nitrocellulose membrane. Proteins were visualized using a reversible protein stain (Memcode; Pierce, Thermo Fisher Scientific) and membranes were incubated with the following primary
antibodies: anti-pAKT S473 (9271; Cell Signaling), anti-AKT (05-591;
Millipore), anti-pp70S6K T389 (9234; Cell Signaling), anti-p70S6K
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ITTs and GTTs were performed as previously described (27).
For ITTs, awake mice were injected intraperitoneally with 1 U human insulin (HumulinR; Eli Lilly) per kilogram body weight following a 3 h food withdrawal. For GTTs, awake 16 h-fasted mice
were injected intraperitoneally with 20% (w/v) D-glucose at
2 g/kg body weight. Blood glucose was measured using an Aviva
Nano glucometer (Accu-Chek).
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(2708; Cell Signaling), anti-pERK T202/Y204 (9101; Cell Signaling),
anti-ERK (9102; Cell Signaling), anti-pJNK T183/Y185 (4688; Cell
Signaling), and anti-c-Jun N-terminal kinase (JNK) (9252; Cell
Signaling). Immunoblots were developed using the Western Lightning Plus-ECL enhanced chemiluminescence substrate (Perkin
Elmer). Densitometric analysis was performed using Image Lab
software (Bio-Rad).

Mitochondrial analysis

Citrate synthase activity assay
Citrate synthase activity was determined as previously described,
with minor modifications (33). Permeabilized skeletal muscle fibers or C2C12 cell pellets were homogenized in buffer containing
20 mM HEPES, 10 mM EDTA, and 10 l/ml protease inhibitor
(pH 7.4), and incubated on ice for 30 min. Samples were spun at
600 g for 20 min at 4°C. An aliquot of the supernatant was used to
determine protein concentration using a BCA assay. Homogenates
were frozen for 1 h at 80°C to liberate citrate synthase from the
mitochondrial matrix. The reaction was initiated by the addition
of 227.5 l of reaction buffer containing 20 mM HEPES, 2 mM
EGTA, 220 mM sucrose, 40 mM KCl, 0.1 mM DTNB, and 0.3 mM
acetyl-CoA (pH 7.4) at 25°C. After 5 min, a baseline reading was
obtained at 412 nm. The reaction was started by the addition of
0.5 mM oxaloacetate and monitored at 412 nm for 10 min.

Adult ventricular cardiomyocyte culture and sarcomere
shortening analysis
Cardiomyocytes were isolated from mice as previously described (37). Cells were seeded on laminin-coated coverslips
(4,000 cells/cm2) in plating medium. Following a 2 h incubation,
cardiomyocytes were transferred to EBSS medium (Thermo
Fisher Scientific) containing 1.25 mM Ca and electrically stimulated at 1 Hz. Sarcomere dimensions during contractions were
assessed using a PTI RatioMaster monochromator-based widefield microscope system (Horiba) in single cardiomyocytes. Sarcomere length, fractional shortening {[(sarcomere length at peak of
relaxation – sarcomere length at peak of contraction)/sarcomere
length at peak of relaxation] × 100}, sarcomere shortening rate,
and sarcomere relengthening rate were determined.

Statistical analysis
Results are expressed as mean ± SEM. Comparisons between
two groups were performed using an unpaired two-tailed Student’s t-test. Comparisons between multiple groups were performed using a paired or unpaired one- or two-way ANOVA
followed by a Tukey or Sidak post hoc test, as appropriate. All
statistical analysis was performed using Prism (GraphPad Software). P values of less than 0.05 were considered statistically
significant.

Tissue lipid analysis
For targeted lipidomic analysis in muscle, total lipids of weighed
muscle tissue explants (50–100 mg) were extracted twice according to Folch, Lees, and Sloane Stanley (34) using 4 ml chloroform/methanol (2/1, v/v) containing 500 pmol of butylated
hydroxytoluene, 1% acetic acid, and 100 pmol of internal standards (d18:1/17:0 ceramide, 14:0-14:0 diacylglycerol (DG), 15:015:0-15:0 TG; Avanti Polar Lipids) per sample. Extraction was
performed under constant shaking for 90 min at room temperature. After addition of 800 l of dH2O and further incubation for
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RESULTS
Male mice with heterozygous ATX deficiency have
reduced obesity and improved glucose homeostasis on an
obesogenic “Western” diet
Although prior studies have suggested that ATX haploinsufficiency or adipocyte-specific ATX deficiency improves
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Respiratory oxygen flux in permeabilized soleus muscle fibers
and C2C12 myotubes was measured in high-resolution using the
Oxygraph-2k (OROBOROS Instruments). Permeabilized fibers
were prepared as described (32). Briefly, soleus muscles were incubated in ice-cold biopsy preservation solution [10 mM Ca-EGTA
buffer, 0.1 M free Ca, 20 mM imidazole, 20 mM taurine, 50 mM
K-MES, 0.5 mM DTT, 6.56 mM MgCl2, 5.77 mM ATP, and 15 mM
phosphocreatine (pH 7.1)]. Excess connective tissue, fat, and tendons were removed and fiber bundles were mechanically separated using forceps. Fiber bundles were permeabilized in 2 ml of
biopsy preservation solution containing 50 g/ml saponin and
gently agitated on ice for 30 min. Thereafter, fiber bundles were
washed in mitochondrial respiration medium (MiR05) buffer
(0.5 mM EGTA, 3 mM MgCl2-6H2O, 60 mM lactobionic acid,
20 mM taurine, 10 mM KH2PO4, 20 mM HEPES, 110 mM sucrose,
and 1 g/l FAF-BSA); fiber wet weights were obtained; and samples
were placed in the Oxygraph chambers. Samples were assessed in
2 ml of hyper-oxygenated MiR05 buffer at 37°C and reoxygenated
as necessary throughout the protocol. Instrumental background
O2 consumption was corrected using equations determined under the same parameters used for experimental data collection.
C2C12 myotubes (200,000 cells/ml) were incubated with saline or
10 M LPA for 16 h prior to cell permeabilization with 3 g/ml
digitonin and mitochondrial respiration analysis. Thereafter, cells
were collected and stored at 80°C until further analysis. The
respirometric protocol for muscle fibers and C2C12 myotubes involved the sequential addition of substrates, inhibitors, and/or titration of substrates, as indicated. Mitochondrial respiration was
normalized to protein content, as determined by a BCA assay.

30 min at room temperature, samples were spun at 1,000 g for
15 min at room temperature to establish phase separation. The
lower organic phase was collected, 2.5 ml of chloroform were
added to the remaining aqueous phase, and the second extraction was performed as described above (30 min at room temperature with subsequent centrifugation). Combined organic phases
of the double-extraction were dried under a stream of nitrogen
and lipids were resolved in 150 l of 2-propanol/methanol/water
(6/3/1, v/v/v) for UPLC-MS analysis. For protein determination,
the interphase was dried and lysed using 1.5 ml NaOH/SDS
(0.3 N/0.1%).
Chromatographic separation was modified after Knittelfelder
et al. (35) using an AQUITY-UPLC system (Waters Corporation)
equipped with a Kinetex EVO-C18 column (2.1 × 50 mm, 1.7 m;
Phenomenex), starting a 15 min linear gradient with 100% solvent A (methanol/water, 1/1, v/v; 10 mM ammonium acetate,
0,1% formic acid, and 8 M phosphoric acid).
An EVOQ Elite™ triple quadrupole mass spectrometer (Bruker)
equipped with an ESI source was used for detection. Lipid species
were analyzed by selected reaction monitoring (DG: [MNH4]+ to
[RCOO+58]+ of the respective esterified fatty acid, 15 eV, 50 ms;
TG: [MNH4]+ to [DG-H2O]+ of the respective DG, 23eV, 30 ms;
Ceramide: [MH]+ to m/z 264.3, 22 eV, 60 ms; the resolution of
Q1/Q3 were set to 0.7). Data were acquired with MS Workstation
(Bruker). Data were normalized for recovery, extraction, and ionization efficacy by calculating analyte/internal standard ratios
(AU) and expressed as AU per milligram of tissue protein.
Analysis of TG accumulation in the liver (20 mg) was performed using a colorimetric assay (Infinity Triglycerides reagent;
Thermo Fisher Scientific) as previously described (36).
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serum ATX activity (supplemental Fig. S2B) and insulinstimulated AKT phosphorylation in muscle when compared with chow-fed mice (supplemental Fig. S2C, D).
Therefore, subsequent studies were performed in male
mice.
HFHS-fed ATX+/ mice have improved insulin signaling in
liver, white adipose tissue, heart, and skeletal muscle
To examine whether enhanced tissue insulin function
underlies the improvement in glucose homeostasis in HFHS+/
mice, we performed in vivo insulin signaling
fed ATX
analysis in metabolically relevant tissues. HFHS-fed WT
mice developed insulin resistance in the liver and PGAT, as
was evidenced by a 2- to 3-fold decrease in insulin-stimulated phosphorylation of AKT at S473 (Fig. 2A, B). Importantly, insulin-stimulated AKT phosphorylation in the liver
was significantly improved in HFHS-fed ATX+/ mice compared with HFHS-fed WT mice, which was associated with
reduced hepatic TG accumulation (supplemental Fig.
S3E). Insulin-stimulated AKT phosphorylation was also unchanged in the PGAT of HFHS-fed ATX+/ mice compared
with chow-fed ATX+/ mice (Fig. 2A, B), suggesting that
ATX+/ mice are resistant to HFHS diet-induced insulin
resistance in liver and PGAT. These results corresponded
with insulin-stimulated p70S6K phosphorylation at T389
where p70S6K phosphorylation was higher in liver and
PGAT from insulin-injected HFHS-fed ATX+/ mice compared with WT mice (supplemental Fig. S3A–C).
We next examined insulin signaling in cardiac and skeletal muscle. As with the liver, HFHS-fed WT mice showed
markedly impaired insulin-stimulated AKT and p70S6K

Fig. 1. Partial ATX deficiency protects from HFHS diet-induced obesity and metabolic dysfunction in male mice. Body weight gain (A),
food intake (B), peripheral fat accumulation (C), PGAT weight (D), BAT weight (E), GTT following an intraperitoneal injection with
D-glucose at 2 g/kg body weight (F), and ITT following an intraperitoneal injection with human insulin at 1 U/kg body weight (G) in chowand HFHS-fed WT and ATX+/ mice (n = 14–26). Blood glucose (H) and serum insulin (I), TGs (J), and NEFA (K) in chow- and HFHS-fed
WT and ATX+/ mice following a 3 h food withdrawal (n = 5–13). A–K: Statistical analysis was performed using a two-way ANOVA followed
by a Tukey’s multiple comparison test. A: *P < 0.05, **P < 0.01 versus ATX +/ HFHS. B–E, H–K: #P < 0.05, ##P < 0.01, ###P < 0.001, ####P < 0.0001
versus chow; *P < 0.05 as indicated. F, G: *P < 0.05, **P < 0.01, ***P < 0.001 for WT HFHS versus chow; $$P < 0.01 for ATX +/ HFHS versus
chow.
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systemic glucose homeostasis in mice fed a high-fat diet,
the effect of ATX deficiency on obesity and tissue insulin
signaling remains unclear (4, 5). To clarify the role of ATX
in diet-induced obesity, glucose metabolism, and insulin
signaling, we fed male WT and ATX+/ mice chow or HFHS
diet for 20 weeks. In agreement with previous studies (5,
26), plasma LPA levels, ATX activity, and ATX protein content were markedly reduced in ATX+/ mice compared
with WT mice (supplemental Fig. S1A–E). Body weights
were similar between WT and ATX+/ mice immediately
prior to HFHS feeding (WT, 22.45 ± 0.26 g; ATX+/, 22.30
± 0.56 g; n = 15–18). However, HFHS-fed ATX+/ mice
showed significantly reduced body weight gain compared
with HFHS-fed WT mice, while food intake was unchanged
between genotypes (Fig. 1A, B). In agreement with lower
body weight gain, HFHS-fed ATX+/ mice showed reduced
peripheral fat accumulation and PGAT and BAT weights
(Fig. 1C–E). Furthermore, HFHS-fed ATX+/ mice had improved glucose tolerance and insulin sensitivity, as assessed
by a GTT and an ITT, respectively (Fig. 1F, G). ATX+/
mice were also protected from HFHS diet-induced hyperglycemia (Fig. 1H), hyperinsulinemia (Fig. 1I), and hypertriglyceridemia (Fig. 1J), while serum NEFA levels were
similar between groups (Fig. 1K). Taken together, these
data suggest that partial ATX deficiency protects from dietinduced obesity and impaired glucose and lipid homeostasis in male mice.
HFHS-induced body weight gain was much less pronounced in female mice and was unchanged between genotypes (supplemental Fig. S2A). Modest body weight gain
in female HFHS-fed WT mice was associated with unchanged
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phosphorylation in the heart compared with chow-fed WT
mice (Fig. 2A, D; supplemental Fig. S3A, D). AKT and
p70S6K phosphorylation was unchanged in cardiac muscle
from HFHS-fed ATX+/ mice compared with chow-fed controls (Fig. 2A, D; supplemental Fig. S3A, D). Preserved
insulin-stimulated AKT phosphorylation in hearts from
HFHS-fed ATX+/ mice was associated with a resistance
toward HFHS diet-induced contractile dysfunction in
cardiomyocytes isolated from ATX+/ mice (Fig. 3A–E).

HFHS feeding led to a decrease in fractional shortening,
rate of contraction, and rate of relaxation in cardiomyocytes from WT mice, but not ATX+/, mice (Fig. 3A–E).
Similar to cardiac muscle, insulin-stimulated AKT phosphorylation in the gastrocnemius and soleus muscle, which
consist of primarily glycolytic and oxidative fibers, respectively, was improved in HFHS-fed ATX+/ mice compared
with WT mice (Fig. 4A–C). In addition, gastrocnemius
and soleus muscles from HFHS-fed ATX+/ mice were

Fig. 3. Contractile properties are preserved in cardiomyocytes from HFHS-fed ATX+/ mice. Sarcomere
length (A), sarcomere shortening trace (mean) (B),
fractional shortening (C), sarcomere shortening rate
(D), and sarcomere relengthening rate (E) in ventricular cardiomyocytes isolated from chow- and HFHS-fed
male WT and ATX+/ mice (n = 7–12 cardiomyocytes
from two to three mice per group, 10 contractions per
cardiomyocyte). Statistical analysis was performed using a two-way ANOVA followed by a Sidak multiple
comparison test. A, C–E: *P < 0.05, **P < 0.01 versus
chow; #P < 0.05, ##P < 0.01 as indicated.
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Fig. 2. HFHS-fed ATX+/ mice show improved insulin signaling in liver, PGAT, and heart. Immunoblot and densitometric analysis of AKT
phosphorylation at S473 in liver (A, B), PGAT (A, C), and heart (A, D) from chow- and HFHS-fed male WT and ATX+/ mice subjected to a
3 h food withdrawal, followed by the intraperitoneal injection of saline or 10 U/kg insulin (n = 4–6). B–D: Statistical analysis was performed
using a two-way ANOVA followed by a Tukey’s multiple comparison test. *P < 0.05, ***P < 0.001, ****P < 0.0001 versus saline; #P < 0.05, ##P <
0.01, ####P < 0.0001 as indicated. C, chow; H, HFHS.
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protected from impaired insulin-stimulated p70S6K phosphorylation (supplemental Fig. S3A, F, G). To determine
whether improvements in skeletal muscle insulin signaling
in HFHS-fed ATX+/ mice are maintained in the absence
of circulating or neuronal factors, we performed insulin
signaling analysis in soleus muscle ex vivo (Fig. 4A, D). Similar to improved insulin signaling in gastrocnemius and soleus muscles from HFHS-fed ATX+/ mice in vivo (Fig.
4A–C), insulin-stimulated AKT phosphorylation ex vivo
was higher in soleus muscle from HFHS-fed ATX+/ mice
than HFHS-fed WT mice (Fig. 4A, D). Furthermore, sustained muscle insulin signaling in HFHS-fed ATX+/ mice
was associated with preserved insulin-stimulation of glucose transport in soleus muscle of HFHS-fed ATX+/ mice
ex vivo, while the ability of insulin to stimulate glucose
transport was reduced in soleus muscle from HFHS-fed WT
mice compared with the chow control mice (Fig. 4E, F). In
agreement with sustained insulin-stimulated glucose transport in HFHS-fed ATX+/ mice, soleus muscle from ATX+/
mice was protected from HFHS-induced decline of Glut4
mRNA levels (Fig. 4G), while Glut1 mRNA was unchanged
between groups (Fig. 4H). Taken together, these data

suggest that partial ATX deficiency protects against insulin
resistance in metabolically active and insulin-responsive tissues, including liver, white adipose tissue, myocardium,
and skeletal muscle. Our data also suggest that sustained
insulin signaling in the heart underlies, in part, the resistance of cardiomyocytes from ATX+/ mice toward HFHS
diet-induced contractile dysfunction. Moreover, our data
suggest that preserved insulin stimulation of glucose transport in skeletal muscle contributes to the improved systemic glucose homeostasis in obese ATX+/ mice.
Improved insulin sensitivity in skeletal muscle
+/
of HFHS-fed ATX mice is not associated with
marked alterations in ectopic lipid accumulation
To explore possible mechanisms that underlie the blunted
+/
insulin resistance in skeletal muscle of HFHS-fed ATX
mice, we examined the accumulation of lipids that might
contribute to obesity-induced muscle insulin resistance via
lipidomic analysis in gastrocnemius muscle. Total ceramide
levels were unchanged regardless of diet or genotype
(Fig. 5A). When examining the major ceramide species,
we noted a slight, but significant, decrease in unsaturated
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Fig. 4. HFHS-fed ATX+/ mice show improved insulin signaling in skeletal muscle in vivo and ex vivo. Immunoblot and densitometric
analysis of AKT phosphorylation at S473 in gastrocnemius muscle (Gastrocn.) (A, B) and soleus muscle (A, C) from chow- and HFHS-fed male
WT and ATX+/ mice subjected to a 3 h food withdrawal, followed by the intraperitoneal injection of saline or 10 U/kg insulin (n = 4–6).
A, D: Immunoblot and densitometric analysis of AKT phosphorylation at S473 in soleus muscle isolated from chow- and HFHS-fed male WT
and ATX+/ mice following incubation with saline or 33 nM insulin ex vivo (n = 3–5). Glucose transport rate (E) and fold stimulation (F) of
glucose transport in soleus muscle from chow- and HFHS-fed male WT and ATX+/ mice incubated with saline or 33 nM insulin ex vivo. Gene
expression analysis of Glut4 (G) and Glut1 (H) in soleus muscle from chow- and HFHS-fed male WT and ATX+/ mice (n = 7–10). B–H:
Statistical analysis was performed using a two-way ANOVA followed by a Tukey’s multiple comparison test. B–E: *P < 0.05, ***P < 0.001,
****P < 0.0001 versus saline; #P < 0.05, ####P < 0.0001 as indicated. F–H: *P < 0.05, **P < 0.01 versus chow. C, chow; H, HFHS.
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species (24:1) and a shift toward saturated (22:0) species in
HFHS-fed compared with chow-fed mice of both genotypes
(Fig. 5B). Total DG levels increased 2.5-fold in HFHS-fed
versus chow-fed WT mice (Fig. 5C). Total DG levels were
similar between genotypes in both chow- and HFHS-fed
states, although DG concentrations were not significantly
increased in HFHS-fed versus chow-fed ATX+/ mice (Fig.
5C). When examining the DG acyl chain composition, we
noted a HFHS diet-induced increase in 36:2 DGs in WT
and ATX+/ mice, and a decrease in 32:0 and 38:4 DG species in HFHS-fed compared with chow-fed ATX+/ mice
(Fig. 5D). Total TG levels were increased in HFHS-fed WT
and ATX+/ mice compared with the chow-fed controls
and were similar between genotypes (Fig. 5E). TG species
analysis revealed a HFHS diet-induced increase in TGs with
longer acyl chains (54:2 and 54:3) and a decrease in TGs
with shorter acyl chains (48:2 and 48:3) (Fig. 5F). The 48:3
TGs were also changed between genotypes with lower levels detected in chow- and HFHS-fed ATX+/ mice compared with WT mice (Fig. 5F). Taken together, these data
suggest that partial ATX deficiency modestly protects from
obesity-induced increases in DG accumulation and results
in altered TG species composition in skeletal muscle. These
data also suggest that improved muscle insulin sensitivity in
ATX+/ mice is not accompanied by major changes in muscle lipid accumulation.
Improved glucose homeostasis in HFHS-fed ATX+/ mice
is associated with enhanced mitochondrial function in
skeletal muscle
To determine whether improved mitochondrial function contributes to the improved glucose homeostasis
+/
and insulin sensitivity in muscle of HFHS-fed ATX mice,
we performed high-resolution respirometric analysis of
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mitochondria from permeabilized soleus muscle fibers
(Fig. 6A, B, D, E). Interestingly, during pyruvate oxidation,
mitochondria from HFHS-fed ATX+/ muscle showed a
significant increase in respiratory oxygen consumption following the addition of ADP and succinate compared with
chow-fed ATX+/ and HFHS-fed WT controls (Fig. 6A).
These changes were not evident in HFHS-fed WT mice.
Uncoupled respiration, induced by addition of carbonyl
cyanide p-trifluoro-methoxyphenyl hydrazine (FCCP), was
also significantly elevated in HFHS-fed ATX+/ muscle fibers (Fig. 6B). Increased mitochondrial respiration in the
presence of pyruvate corresponded with increased citrate
synthase activity in fibers from HFHS-fed ATX+/ mice
(Fig. 6C), which is suggestive of elevated mitochondrial
content (38). Mitochondrial respiration upon incubation
with fatty acyl-carnitines was comparable between groups
(Fig. 6D). Citrate synthase activity was reduced in fibers
incubated with fatty acyl-carnitines and was not different
between groups (data not shown), consistent with an inhibitory effect of fatty acyl esters on citrate synthase activity
(39). Taken together, these data suggest that increased mitochondrial glucose/pyruvate oxidation is associated with
blunted insulin resistance in skeletal muscle and contributes to improved glucose homeostasis in HFHS-fed ATX+/
mice.
LPA impairs insulin signaling and exacerbates
palmitate-induced insulin resistance in C2C12 myotubes
We next sought to investigate whether the resistance
+/
mice toward obesity-induced impairment of
of ATX
skeletal muscle insulin signaling is due to a direct effect of
LPA on skeletal muscle insulin function. C2C12 myotubes
were incubated for 18 h in the absence or presence of
1 and 10 M 1-oleoyl-LPA, mimicking physiological and
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Fig. 5. HFHS-fed ATX+/ mice do not show marked changes in skeletal muscle lipid accumulation. Levels of total ceramides (A), ceramide
species (B), total DGs (C), DG species (D), total TGs (E), and TG species (F) in gastrocnemius muscle from chow- and HFHS-fed male WT
and ATX+/ mice subjected to a 3 h food withdrawal (n = 8). A–F: Statistical analysis was performed using a two-way ANOVA followed by a
Tukey’s multiple comparison test. *P < 0.05, **P < 0.01, ****P < 0.0001 versus chow; ##P < 0.01, ####P < 0.0001 as indicated.
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pathophysiological LPA concentrations (1, 4, 5, 40) (supplemental Fig. S1A). Cells were also simultaneously incubated in the absence or presence of 0.8 mM palmitate to
induce insulin resistance, as determined by a 2-fold reduction in insulin-stimulated AKT phosphorylation at S473 (Fig.
7A, B). At baseline, incubation with LPA impaired insulinstimulated AKT phosphorylation in C2C12 myotubes, similar to palmitate (Fig. 7A, B). Moreover, LPA exacerbated
the palmitate-induced reduction in insulin-stimulated AKT
phosphorylation (Fig. 7A, B). Prolonged treatment of
C2C12 cells with LPA has been linked to the activation of
JNK and ERK, both of which are associated with the development of insulin resistance (41–43). Consistent with this
notion, LPA-induced impairment of insulin function and
exacerbation of palmitate-induced insulin resistance in
C2C12 cells was associated with an upregulation of JNK
and ERK phosphorylation (Fig. 7A, C, D). Taken together,
these data suggest that exposure of muscle cells to LPA directly promotes the development of insulin resistance and
worsens impaired insulin signaling induced by a lipotoxic
milieu.
LPA impairs mitochondrial respiration in C2C12
myotubes
To determine whether exogeneous LPA modulates mitochondrial function in muscle cells, insulin-sensitive and
insulin-resistant C2C12 myotubes were incubated with LPA
and subjected to respirometric analysis (Fig. 8A, B). Insulin-resistant C2C12 myotubes showed significantly reduced
mitochondrial respiration in the presence of fatty acyl

carnitines and pyruvate compared with insulin-sensitive
cells (Fig. 8A). Addition of LPA in insulin-resistant myotubes further depressed mitochondrial respiration (Fig.
8A). LPA also had an effect on mitochondrial respiration
in insulin-sensitive myotubes, leading to a significant reduction in pyruvate-supported mitochondrial O2 flow (Fig.
8A). Moreover, LPA treatment significantly reduced uncoupled respiration in insulin-resistant myotubes (Fig. 8B).
In accordance with increased citrate synthase activity in
muscle from HFHS-fed ATX+/ mice (Fig. 6C), incubation
with LPA reduced citrate synthase activity in insulin-sensitive
and insulin-resistant myotubes, consistent with impaired
mitochondrial respiration (Fig. 8C). Taken together, these
data suggest that LPA directly impairs mitochondrial function in C2C12 myotubes.

DISCUSSION
Recent studies have implicated the ATX-LPA axis in obesity and impaired glucose homeostasis (4, 5, 19–21, 23).
Improvements in obesity-induced insulin resistance and
glucose intolerance in ATX mutant mice were primarily
ascribed to changes in adipose tissue metabolism and function (4, 5). It remained unclear whether changes in insulin
signaling and mitochondrial function in metabolically relevant tissues contribute to the protective effect of ATX deficiency toward the obesity-induced impairment of glucose
homeostasis. In this study, we show that amelioration of
obesity and systemic insulin resistance in HFHS-fed mice
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+/

Fig. 6. Mitochondrial pyruvate oxidation is increased in skeletal muscle from HFHS-fed ATX
mice. Mitochondrial respiration (A, D)
and uncoupled respiration (B, E) during pyruvate oxidation (A, B) and fatty acid oxidation (D, E) in permeabilized soleus muscle fibers
from chow- and HFHS-fed male WT and ATX+/ mice. C: Citrate synthase activity in fibers subjected to pyruvate oxidation analysis (n = 5–6).
A–E: Statistical analysis was performed using a two-way ANOVA followed by a Tukey’s multiple comparison test. ##P < 0.01 versus chow;
*P <0,05, **P < 0.01, ****P <0.0001 as indicated. M, malate; Pyr, pyruvate; Palm, palmitoyl-carnitine; D, ADP; Oct, octanoyl-carnitine;
R, rotenone; S, succinate; AmA, antimycin A.
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with partial ATX deficiency is associated with increased insulin signaling in metabolically active tissues, including
liver, adipose tissue, and heart, as well as protection from
obesity-induced cardiomyocyte dysfunction. In skeletal
muscle, which accounts for the majority of insulin-stimulated glucose disposal (25), partial ATX deficiency led to
improvements in insulin signaling and insulin-stimulated
glucose transport following HFHS feeding. In C2C12 myotubes, LPA directly impaired insulin signaling and exacerbated palmitate-induced insulin resistance. Our data also
show that the ATX-LPA axis influences mitochondrial metabolism in muscle because partial ATX deficiency resulted
in enhanced mitochondrial pyruvate/glucose oxidation in
HFHS-fed mice and LPA directly decreased mitochondrial

pyruvate/glucose oxidation in C2C12 myotubes. Impaired
mitochondrial metabolism was paralleled by corresponding changes in citrate synthase activity, an indicator of mitochondrial function and abundance. Taken together,
these data suggest that the ATX-LPA pathway plays an important role in the development of obesity-induced insulin
resistance and impairs mitochondrial metabolism in skeletal muscle.
Only a few prior studies have examined the effect of
ATX-LPA signaling on tissue insulin function (21, 24, 44).
Rancoule et al. (24) showed that administration of a
LPA1/3 receptor antagonist in high-fat diet-fed mice for 3
weeks improves insulin sensitivity and increases insulinstimulated glucose oxidation in muscle ex vivo, suggesting

Fig. 8. LPA impairs mitochondrial respiration in
C2C12 myotubes. Mitochondrial respiration (A), uncoupled respiration (B), and citrate synthase activity
(C) in permeabilized C2C12 myotubes incubated in
the absence or presence of 0.8 mM palmitate and 0 or
10 M LPA for 18 h (n = 5–6). A–C: Statistical analysis
was performed using a two-way ANOVA followed by a
Tukey’s multiple comparison test. *P < 0.05, **P <
0.01, ****P < 0.0001 versus insulin sensitive; #P < 0.05,
##
P < 0.01, ####P < 0.0001 versus no LPA controls. IS,
insulin sensitive; IR, insulin resistant. M1/2, malate;
Palm, palmitoyl-carnitine; D, ADP; Oct, octanoyl-carnitine; Pyr, pyruvate; R, rotenone; S, succinate; AmA,
antimycin A.
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Fig. 7. LPA impairs insulin signaling and exacerbates palmitate-induced insulin resistance in C2C12 myotubes. Immunoblot and densitometric analysis of AKT phosphorylation at S473 (A, B), ERK phosphorylation at T202/Y204 (A, C), and JNK phosphorylation at TT183/Y185 (A, D)
in C2C12 myotubes incubated in the absence or presence of 0.8 mM palmitate and 0, 1, or 10 M LPA for 18 h, followed by stimulation with
20 nM insulin for 15 min (n = 6). B–D: Statistical analysis was performed using a two-way ANOVA followed by a Tukey’s multiple comparison
test. *P < 0.05, ****P < 0.0001 versus saline; #P < 0.05, ##P < 0.01, ###P < 0.001, ####P < 0.0001 versus no LPA controls. IS, insulin sensitive; IR,
insulin resistant.
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potential in BAT at baseline and following diet-induced
obesity (5). However, it is presently unclear whether the
ATX-LPA-induced decrease in mitochondrial function in
BAT is secondary to changes in preadipocyte differentiation (5, 23). Our study suggests that the ATX-LPA pathway
plays a role in modulating mitochondrial function during
insulin resistance by reducing oxidative metabolism and
decreasing citrate synthase activity, an indicator of mitochondrial density, in muscle. Our data also suggest that
partial ATX deficiency in vivo selectively increases mitochondrial pyruvate oxidation following diet-induced obesity. Unaltered fat oxidation in muscle from HFHS-fed
ATX+/ mice may explain the absence of major changes in
muscle lipid accumulation, despite an overall decrease in
obesity in these mice. Because we assessed muscle lipid accumulation in mice subjected to a 3 h food withdrawal, it
remains to be determined whether lipid levels are also similar between genotypes following prolonged fasting. Nevertheless, these data confirm a study by Nishimura et al. (5)
showing that ectopic fat accumulation in skeletal muscle,
liver, and heart was similar in WT and ATX+/ mice with
diet-induced obesity. Besides affecting insulin signaling,
the ATX-LPA pathway has also been suggested to modulate
other important processes in skeletal muscle, including the
migration of satellite cells (47), secretion of chemokines
(48), and regulation of intracellular calcium levels (49). It
would be interesting to determine whether ameliorated insulin resistance in skeletal muscle from ATX+/ mice is
linked to changes in these processes in vivo.
Taken together, our study suggests that, in addition to
reduced adipose tissue accumulation, improved insulin signaling in adipose tissue, liver, and muscle contributes to
preserved global insulin sensitivity in mice with partial ATX
deficiency. Our data also suggest that the ATX-LPA pathway directly impairs insulin signaling, insulin-stimulated
glucose transport, and mitochondrial function in skeletal
muscle (Fig. 9). Because impaired insulin signaling and
metabolism in skeletal muscle are primary drivers of systemic
insulin resistance and hyperglycemia (50), we propose that
the obesity-induced upregulation of ATX and LPA receptor signaling in muscle are critical mechanisms of insulin
resistance. Therefore, modulators of the ATX-LPA pathway

Fig. 9. Proposed role of the ATX-LPA axis in skeletal
muscle insulin signaling and mitochondrial function.
In diet-induced obesity, increases in ATX-LPA contribute to impaired skeletal muscle insulin signaling and
glucose transport, a primary driver of systemic insulin
resistance and type 2 diabetes. Inhibition of the ATXLPA pathway enhances skeletal muscle insulin signaling, glucose transport, and mitochondrial glucose
oxidation in an obesogenic milieu, thereby ameliorating diet-induced obesity and glucose homeostasis. GSV,
Glut4 storage vesicles; P, phosphorylation; G, glucose.
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that LPA signaling through LPA1/3 impairs muscle insulin
function. However, other effects of systemic LPA1/3 inhibition, including increased pancreatic islet mass and liver
glycogen storage, may have contributed to changes in glucose metabolism in muscle (24). Two very recent studies
have provided more direct evidence for an inhibitory role
of ATX-LPA signaling on tissue insulin function (21, 44).
Acute pretreatment of primary rat hepatocytes with LPA
decreased insulin-stimulated AKT phosphorylation, glucokinase, and SREBP-1c expression, PI3K activation, and glycogen synthesis, likely via LPA1 and/or LPA3 (44).
Moreover, inhibition of ATX protected against interleukin
6-induced impairment of insulin-stimulated AKT phosphorylation in 3T3-L1 adipocytes (21). We have previously
shown that 24 h inhibition of ATX in 3T3-L1 adipocytes
exposed to high glucose and insulin does not alter insulin
resistance (22). However, it is possible that prolonged ATX
inhibition is necessary to alter insulin signaling in this insulin-resistant adipocyte model. In this study, we show that
reduced ATX function ameliorates insulin resistance in
adipose tissue, liver, heart, and skeletal muscle in vivo. Incubation with LPA directly impairs insulin signaling in
myotubes, possibly through activation of JNK, ERK, or
other stress kinases (41). Future studies should identify the
LPA receptor(s) and precise mechanisms that mediate
LPA-induced muscle insulin resistance. It is possible that
G13, a mediator downstream of most LPA receptors (13),
plays a role in the inhibition of muscle insulin function by
LPA because G13 impairs muscle glucose uptake and systemic insulin sensitivity in high-fat diet-fed mice (45).
Insulin resistance has been linked to altered mitochondrial function, although it remains uncertain whether
changes in mitochondrial capacity are a cause or a consequence of insulin resistance (46). The ATX-LPA axis appears to impair mitochondrial function in BAT (5, 23).
Microarray analysis of primary BAT preadipocytes differentiated with LPA or ATX inhibitor revealed that the
ATX-LPA pathway decreases the expression of many genes
involved in mitochondrial function (23). Consistent with
this observation, a study employing mice with adiposespecific ATX deficiency also suggested that the ATX-LPA
pathway decreases mitochondrial content and membrane
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may present novel strategies toward the prevention and
treatment of obesity-associated insulin resistance and type
2 diabetes.
The authors thank Angella Mercer for technical assistance.
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